Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
Gilvocarcin V
As low as
CHF 90.00
In stock
Only %1 left
BVT-0256-C100100 µgCHF 90.00
BVT-0256-C250250 µgCHF 145.00
BVT-0256-M0011 mgCHF 370.00
Specifications / Handling
| Product Details | |
|---|---|
| Synonyms | Anandimycin A; Toromycin A; NSC 338943; DC-38-V; Antibiotic 1072B |
| Product Type | Chemical |
| Properties | |
| Formula |
C27H26O9 |
| MW | 494.5 |
| CAS | 77879-90-4 |
| RTECS | DI2240000 |
| Source/Host Chemicals | Isolated from Streptomyces sp. Gö 3592. |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | Yellow solid. |
| Solubility | Soluble in DMSO. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by BioViotica. |
| InChi Key | XCWHINLKQMCRON-UCDARZNSSA-N |
| Smiles | [H][C@]1(O[C@@H]([C@H](O)[C@H]1O)C1=C2C3=C(C=C(OC)C2=C(O)C=C1)C1=C(OC)C=C(C=C)C=C1C(=O)O3)[C@@H](C)O |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light when in solution. |
| Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. Stock solutions are stable for at least 3 months when stored at -20°C. |
| Documents | |
| Safety Data Sheet |
Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Scientific Background Information
Product Description
- Antibiotic.
- Antitumor compound.
- Weakly active against Gram-positive bacteria and fungi.
- Mediates a unique cross-linking reaction between DNA and histone H3 by light.
- Single strand scission and covalent binding to DNA after photoactivation.
Product-specific References
- Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities: H. Nakano, et al.; J. Antibiot. (Tokyo) 34, 266 (1981)
- Activation of antitumor agent gilvocarcins by visible light: R.K. Elespuru and S.K. Gonda; Science 223, 69 (1984)
- Photosensitized DNA breaks and DNA-to-protein crosslinks induced in human cells by antitumor agent gilvocarcin V: M.J. Peak, et al.; Chem. Biol. Interact. 67, 267 (1988)
- Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II: A. Lorico & B. H. Long; Eur. J. Cancer 29A, 1985 (1993)
- Photophysical properties of gilvocarcins V and M and their binding constant to calf thymus DNA: R. Oyola, et al.; Photochem. Photobiol. 65, 802 (1997)
- Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivatedgilvocarcin V in human fibroblasts: A. Matsumoto and P.C. Hanawalt; Cancer Res. 60, 3921 (2000)
- The complete gene cluster of the antitumor agent gilvocarcin V and its implication for the biosynthesis of the gilvocarcins: C. Fischer, et al.; J. Am. Chem. Soc. 125, 7818-7819 (2003)
- Multi-oxygenase complexes of the gilvocarcin and jadomycin biosyntheses: M. K. Kharel, et al.; J. Am. Chem. Soc. 129, 3780-3781 (2007)
- Inactivation of the ketoreductase gilU gene of the gilvocarcin biosynthetic gene cluster yields new analogues with partly improved biological activity: T. Liu, et al.; Chem Bio Chem 10, 278-286 (2009)
- Total synthesis of the antitumor natural product polycarcin V and evaluation of its DNA binding profile: X. Cai, et al.; Org. Lett. 16, 2962 (2014)
You're in the Switzerland store. Not in Switzerland? Choose your country
You're in the Switzerland store (prices in CHF, shipping to Switzerland only). Ordering from another country? Please select it below.
Please note that not all products are available in every country store. Choose your country before starting the ordering process.
Country
Switzerland
United Kingdom
France
Germany
Austria
Italy
South Korea
United States
Argentina
Australia
Belgium
Bosnia and Herzegovina
Brazil
Canada
Chile
China
Colombia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
Greece
Hong Kong
Hungary
India
Iran
Iraq
Ireland
Israel
Japan
Latvia
Lithuania
Luxembourg
Malaysia
Mexico
Netherlands
New Zealand
Norway
Pakistan
Peru
Poland
Portugal
Romania
Russia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Syria
Taiwan
Thailand
Turkey
Uruguay
Venezuela
Other Country
No country found




Download PDF




